BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

465 related articles for article (PubMed ID: 11979303)

  • 21. [Effect of growth factor on the phenotype of subpopulations and on the kinetics of CD34+ cells in the peripheral blood and in grafts of peripheral stem cells in patients with non-Hodgkin's lymphoma indicated for autologous peripheral blood stem cell transplantation].
    Klabusay M; Lysák D; Hrabcáková V; Navrátil M; Coupek P; Mayer J
    Cas Lek Cesk; 2008; 147(6):319-24. PubMed ID: 18724529
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of recombinant human Steel factor (c-kit ligand) on early cord blood hematopoietic precursors.
    Abboud MR; Xu F; Payne A; Laver J
    Exp Hematol; 1994 Apr; 22(4):388-92. PubMed ID: 7512047
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Growth factor stimulation of cryopreserved CD34+ bone marrow cells intended for transplant: an in vitro study to determine optimal timing of exposure to early acting cytokines.
    Ratajczak MZ; Ratajczak J; Kregenow DA; Gewirtz AM
    Stem Cells; 1994 Nov; 12(6):599-603. PubMed ID: 7533578
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ex vivo expansion of CD34-positive peripheral blood progenitor cells from patients with non-Hodgkin's lymphoma: no evidence of concomitant expansion of contaminating bcl2/JH-positive lymphoma cells.
    Yao M; Fouillard L; Lemoine FM; Bouchet S; Firat H; Andreu G; Gorin NC; Douay L; Lopez M
    Bone Marrow Transplant; 2000 Sep; 26(5):497-503. PubMed ID: 11019838
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Long-lasting decrease of marrow and circulating long-term culture initiating cells after allogeneic bone marrow transplant.
    Selleri C; Maciejewski JP; De Rosa G; Raiola A; Risitano AM; Picardi M; Pezzullo L; Luciano L; Ricci P; Varriale G; Della Cioppa P; Del Vecchio L; Rotoli B
    Bone Marrow Transplant; 1999 May; 23(10):1029-37. PubMed ID: 10373069
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In leukapheresis products from non-Hodgkin's lymphoma patients, the immature hematopoietic progenitors show higher CD90 and CD34 antigenic expression.
    Villaron EM; Almeida J; Lopez-Holgado N; Sanchez-Guijo FM; Alberca M; Blanco B; Sanchez-Abarca LI; Lopez O; Perez-Simon JA; San Miguel JF; del Cañizo MC
    Transfus Apher Sci; 2007 Oct; 37(2):145-56. PubMed ID: 17983836
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Combined use of growth factors to stimulate the proliferation of hematopoietic progenitor cells after autologous bone marrow transplantation for lymphoma patients.
    Lemoli RM; Fortuna A; Fogli M; Rosti G; Gherlinzoni F; Visani G; Catani L; Gozzetti A; Tura S
    Acta Haematol; 1996; 95(3-4):164-70. PubMed ID: 8677737
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Neutralization of autocrine transforming growth factor-beta in human cord blood CD34(+)CD38(-)Lin(-) cells promotes stem-cell-factor-mediated erythropoietin-independent early erythroid progenitor development and reduces terminal differentiation.
    Akel S; Petrow-Sadowski C; Laughlin MJ; Ruscetti FW
    Stem Cells; 2003; 21(5):557-67. PubMed ID: 12968110
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conditioned medium from primary porcine endothelial cells alone promotes the growth of primitive human haematopoietic progenitor cells with a high replating potential: evidence for a novel early haematopoietic activity.
    Davis TA; Black AT; Kidwell WR; Lee KP
    Cytokine; 1997 Apr; 9(4):263-75. PubMed ID: 9112335
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effect of type I interferons on hematopoietic progenitor cells: failure of interferons to inhibit IL-3-stimulated normal and CML myeloid progenitors.
    Després D; Goldschmitt J; Aulitzky WE; Huber C; Peschel C
    Exp Hematol; 1995 Dec; 23(14):1431-8. PubMed ID: 8542928
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo effects of GM-CSF and IL-3 on hematopoietic cell recovery in bone marrow and blood after autologous transplantation with mafosfamide-purged marrow in lymphoid malignancies.
    Albin N; Douay L; Fouillard L; Laporte JP; Isnard F; Lesage S; Ozsahin H; Bardinet D; Najman A; Gorin NC
    Bone Marrow Transplant; 1994 Aug; 14(2):253-9. PubMed ID: 7994241
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Preclinical ex vivo expansion of G-CSF-mobilized peripheral blood stem cells: effects of serum-free media, cytokine combinations and chemotherapy.
    Li K; Li CK; Chuen CK; Tsang KS; Fok TF; James AE; Lee SM; Shing MM; Chik KW; Yuen PM
    Eur J Haematol; 2005 Feb; 74(2):128-35. PubMed ID: 15654904
    [TBL] [Abstract][Full Text] [Related]  

  • 33. IL-6 interferes with stimulation of HPP-CFC and large CFU-Mk in conjunction with cytokine combinations from primitive murine marrow cells.
    Cardier JE; Murphy MJ; Erickson-Miller CL
    Stem Cells; 1997; 15(6):437-42. PubMed ID: 9402656
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid isolation and serum-free expansion of human CD34+ cells.
    Lebkowski JS; Schain L; Hall M; Wysocki M; Dadey B; Biddle W
    Blood Cells; 1994; 20(2-3):404-10. PubMed ID: 7538346
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Clinical application of in vitro expansion of cord blood.
    Denning-Kendall PA; Horsley H; Nicol A; Nieda M; Bradley B; Hows JM
    Bone Marrow Transplant; 1998 Jul; 22 Suppl 1():S63-5. PubMed ID: 9715893
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD34(+) CD38(-) and CD34(+) HLA-DR(-) cells in BM stem cell grafts correlate with short-term engraftment but have no influence on long-term hematopoietic reconstitution after autologous transplantation.
    Zubair AC; Kao G; Daley H; Schott D; Freedman A; Ritz J
    Cytotherapy; 2006; 8(4):399-407. PubMed ID: 16923616
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Bone morphogenetic protein (BMP)-7 but not BMP-2 and BMP-4 improves maintenance of primitive peripheral blood-derived hematopoietic progenitor cells (HPC) cultured in serum-free medium supplemented with early acting cytokines.
    Grassinger J; Simon M; Mueller G; Drewel D; Andreesen R; Hennemann B
    Cytokine; 2007 Dec; 40(3):165-71. PubMed ID: 18029192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hematopoietic damage prior to PBSCT and its influence on hematopoietic recovery.
    del Cañizo MC; Lopez N; Vazquez L; Fernandez ME; Ana B; Caballero MD; Amigo ML; Mateos MV; Gutierrez N; San Migue JF
    Haematologica; 1999 Jun; 84(6):511-6. PubMed ID: 10366794
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Characterization of CD34+ subsets derived from bone marrow, umbilical cord blood and mobilized peripheral blood after stem cell factor and interleukin 3 stimulation.
    De Bruyn C; Delforge A; Lagneaux L; Bron D
    Bone Marrow Transplant; 2000 Feb; 25(4):377-83. PubMed ID: 10723580
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [In vitro proliferation and differentiation of bone marrow stem cells of aplastic anemia patients].
    Chen G; Shao Z; Jia H
    Zhonghua Xue Ye Xue Za Zhi; 1999 Oct; 20(10):529-31. PubMed ID: 11721400
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 24.